AG003O08

86541-74-4 | 2-[(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid hydrochloride

AG003O08

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	86541-74-4
Catalog Number	AG003O08(AGN-PC-0V6FYA)
Chemical Name	2-[(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid hydrochloride
IUPAC Name	2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride
InChI	InChI=1S/C24H28N2O5.ClH/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28;/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28);1H/t19-,20-;/m0./s1
InChI Key	VPSRQEHTHIMDQM-FKLPMGAJSA-N
MDL Number	MFCD00895734
Molecular Formula	C24H29ClN2O5
Molecular Weight	460.9505
NSC Number	758920
SMILES	O=C(CN1C([C@H](CCC2=C1C=CC=C2)N[C@@H](CCC3=CC=CC=C3)C(OCC)=O)=O)O.[H]Cl
UNII	N1SN99T69T
Synonyms	benazapril, benazepril, benazepril hydrochloride, benzazepril, Briem, CGS-14824-A, CGS-14824A, Cibacène, Cibacen, Labopal, Lotensin, BENAZEPRIL HYDROCHLORIDE, 86541-74-4, Benazepril HCl, Lotensin, Cibacen, Cibacene, Briem, Tensanil, Zinadril, Cibace, Labopol, Cibacen CHF, Benazepril (hydrochloride), UNII-N1SN99T69T, CGS 14824A HCl, HSDB 7081, CGS 14824A, MFCD00895734, CHEBI:3012, N1SN99T69T, CGS-14824A, DSSTox_CID_25922, DSSTox_RID_81225, DSSTox_GSID_45922, (3S)-3-(((1S)-1-Carboxy-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, 3-ethyl ester, monohydrochloride, C24H29ClN2O5, (3S)-3-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid hydrochloride, 1H-1-Benzazepine-1-acetic acid, 2,3,4,5-tetrahydro-3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2-oxo-, monohydrochloride, (S-(R*,R*))-, 1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, monohydrochloride, (S-(R*,R*))-, 2-((S)-3-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid hydrochloride, 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid hydrochloride, SMR000469199, CAS-86541-74-4, benazcpril, NCGC00095132-01, Lotensin (TN), 2-((S)-3-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid hydrochloride, 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride, AK163656, Benazepril hydrochloride [USAN:JAN], AC1NSFPI, Benazepril hydrochloride [USAN:USP:JAN], benazepril monohydrochloride, CHEMBL1694, SCHEMBL42194, Benazepril Hydrochloride,(S), MLS001076668, MLS001333171, MLS001333172, MLS001401429, C24H28N2O5.HCl, SPECTRUM1505200, CGS-14824A HCL, DTXSID9045922, CTK8B3291, HY-B0093A, KS-00000XHP, VPSRQEHTHIMDQM-FKLPMGAJSA-N, BCPP000350, HMS1922L07, Pharmakon1600-01505200, TWT-8154, Tox21_111441, ANW-42214, Benazepril hydrochloride (JAN/USAN), CCG-39520, NSC758920, s1284, AKOS015888536, Tox21_111441_1, BCP9000387, CS-1796, KS-1397, NC00211, NSC-758920, NCGC00165740-05, (3S)-3-[(1S)-1-Ethoxycarbonyl-3-phenylpropyl]amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic Acid Hydrochloride, AN-14751, CPD000469199, LS-27972, SAM001246712, SC-22757, AX8022900, TL8005618, TR-026954, B3611, FT-0654634, SW197591-3, C07701, D00620, Benazepril hydrochloride, >=98% (HPLC), solid, A841712, SR-01000762893, SR-01000762893-3, Benazepril hydrochloride, VETRANAL(TM), analytical standard, Benazepril hydrochloride, European Pharmacopoeia (EP) Reference Standard, Benazepril for system suitability, European Pharmacopoeia (EP) Reference Standard, Benazepril hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Benazepril hydrochloride, United States Pharmacopeia (USP) Reference Standard, [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid hydrochloride, 1H-1-benzazepine-1-acetic acid,3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-,monohydrochloride,(S-(R*,R*))-, 2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid hydrochloride, 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxidanylidene-4-phenyl-butan-2-yl]amino]-2-oxidanylidene-4,5-dihydro-3H-1-benzazepin-1-yl]ethanoic acid hydrochloride, benazepril, Lotrel, Lotensin HCT, C24-H28-N2-O5.Cl-H, CID5362123, CS-O-30869, B2216, A10123, 109010-60-8, Benazepril hydrochloride, 98.5%, an angiotensin-converting enzyme (ACE) inhibitor - 1G 1g, {(3S)-3-[(1S)-1-Ethoxycarbonyl-3-phenylpropylamino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepin-1-yl}acetic acid hydrochloride, 1H-1-Benzazepine-1-acetic acid, 3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, monohydrochloride, (3S)-, BNZ,

Complexity	619
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	2
Defined Bond Stereocenter Count	0
Exact Mass	460.176g/mol
Formal Charge	0
Heavy Atom Count	32
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	460.955g/mol
Monoisotopic Mass	460.176g/mol
Rotatable Bond Count	10
Topological Polar Surface Area	95.9A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number